Echistatin/BYL-719 impedes epithelial-mesenchymal transition in pulmonary fibrosis induced by silica through modulation of the Integrin β1/ILK/PI3K signaling pathway
- 31 May 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 136, 112368
Abstract
No abstract availableKeywords
Funding Information
- Hebei United University
This publication has 32 references indexed in Scilit:
- Role of non-neuronal cholinergic system in the early stage response of epithelial-mesenchymal transformation related markers in A549 cells induced by coal particlesHeliyon, 2022
- RETRACTED ARTICLE: Integrin-linked kinase affects the sensitivity of esophageal squamous cell carcinoma cells to chemotherapy with cisplatin via the Wnt/beta-catenin signaling pathwayBioengineered, 2022
- Integrin-linked kinase (ILK): the known vs. the unknown and perspectivesCellular and Molecular Life Sciences, 2022
- BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathwayInternational Immunopharmacology, 2020
- Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smad signalingChemico-Biological Interactions, 2020
- Pirfenidone inhibits epithelial-mesenchymal transition and pulmonary fibrosis in the rat silicosis modelToxicology Letters, 2019
- MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1Scientific Reports, 2017
- Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in ratToxicology and Applied Pharmacology, 2016
- Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial–mesenchymal transition (EMT)-related genesActa Histochemica, 2013
- Fibroblasts Contribute to Melanoma Tumor Growth and Drug ResistanceMolecular Pharmaceutics, 2011